ÃâÒßѧÊÔÌâ
a,GOS:?O5 Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
5d7AE^SHsH 1. Fas(CD95)/FasL
Y;X_E7U 2. common chain of cytokine receptor
mzh8<w?ns 3 . TCR/CD3 complex
H+ P&}
3 4. negaive selection of thymocytes
~]MACG:' 5. artificial active immune
Ej\Me 6. anti-idiotypic
CNo'qlvF5N 7. IgSF
S2TyNZbQ 8. Integrin
#
%~PNki 9. chemokine
I`$"6 Xy 10. B7/CD28
eSqKXmH[m ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
{Dc{e5K 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
#-]!;sY> 2. ±È½ÏCTLºÍNKɱÉË°Ðϸ°ûʱʶ±ðºÍɱÉË»úÖƵÄÌص㡣
DRDn;j 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆʵÑé·½°¸¿Ë¡´Ë»ùÒò¡£
p;y\%i_ 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
,P%a0\ `X["Bgk$!T 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
LpQ=Y]{j µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
AHo4%
5 Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
c'wxCqnE
1. B7/CD28
.T>^bLuFy 2. Th1 subset
;JD
/4: 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
]O^C'GzZ 4. antibody affinity maturation
\CY_nn|&g 5. AP-1
>
[%ITqA$ 6. single chain variable fragment£¨ScFv£©
6UK}?+r~ 7. NK cell receptor
qg`8f? 8. Zinkernagel-Doherty phenomenon
{:63% j 9. Ig fold
@@1Sxv_ 10. CD40/CD40L
]8m_+:`= ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
Vx~N`|yY 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØϵ¡£
W
x`|u 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
<`f~Z|/-_( 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹Øϵ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
fF|m~#y Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
ndXUR4 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁÜ°Íϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
S^,q{x*T 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
+kj
d;u# 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æרҵ£©¡£
3G.-JLhs Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
O$K?2- £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
YQ`m;< Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
67{3/(`x 1.Co-stimulators (or co-stimulating molecules)
\Wn0,%x2 2.NK-kB
}jI=* 3.Immunoglobulin superfamily
skeXsls 4.antigen-presenting cell (APC)
u&npUw^Va 5.death domain
B7u4e8(E* 6.CCR and CXCR
)Bb:?!EuEH 7.Lectin (or mitogen)
RHIGNzSz 8.Clusters of differentiation, CD)
5ieF8F% 9.B7 family
qJyGr ? 10.Cytotoxic T lymphocyte, CTL)
<`P7^
'z! 11.IL-15 and IL-15 receptor (IL-15R)
3yXSv1 12.MHC restriction
lI&5.,2MP 13.Affinity-chromatography
7A6: * 14.Cyctosprin A, CsA
"~nUwW|=1 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
$;Nw_S@
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
[Q:C\f] 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
Tz<@k 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£
j}F;Bfq! 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣
)N}.n2Y8W Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
6qYK"^+xu ÃâÒßѧרҵ£º
Pgh)+>ON 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
s<b(@L 1 Ïû»¯ÄÚ¿Æ£º
YX,xC-37y 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
C%T$l8$ ѪҺ²¡Ñ§×¨Òµ£º
7c>{og6 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
ll#_v^ Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
_WB*ArR (רҵ»ù´¡: ÃâÒßѧ)
^>/] Qi Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
r(i!". Z 1. ADCC(antibody dependent cell-mediated cytotoxicity)
'ngx\Lr 2. »·æß¾úËØ(cyclosporin)
i0py5Q 3. KIR(killer cell inhibitory receptor)
"IMq + 4. HLDA(human leucocyte differentiation antigen)
^oH!FN`;{ 5. Interleukin 18(IL-18)
%YV3-W8S0 6. ÕûºÏËØ(integrin)
-l i71.M 7. Fas/FasL
FF'Ul4y 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
n\'@]qG)Z4 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
b+!I_g4P 10. Th1/Th2
?I}0[+)V 11. »ùÒòÒßÃç(DNAÒßÃç)
MgG_D6tDM 12. chemokines and chemokine receptor
}&